arrow
N

Nicolò Bizzarri

fondazione policlinico universitario a gemelli irccs
H指数:25
被引数:2,243

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fluorescence image-guided surgery with tumor-specific probes in gynecologic oncology: a narrative review of emerging evidence and perspectives

妇科肿瘤学中基于肿瘤特异性探针的荧光成像引导手术:新兴证据和前景的叙事性综述

2026-10-230
OA
European Society of Gynecological Oncology Consensus Statement on the prevention of surgical complications in gynecologic oncology

欧洲妇科肿瘤学会关于妇科肿瘤学中预防手术并发症的共识声明

2026-07-270
PRE
Cancer Risk Profile of the Levonorgestrel-Releasing Intrauterine Device: A Narrative Review

左炔诺孕酮释放宫内节育器的癌症风险概况:一篇叙事性综述

Cancers
IF4.4
2026-07-240
OA
Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026

第27届欧洲妇科肿瘤学大会最佳原创研究:ESGO 2026精华

2026-07-110
PRE
Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial

前瞻性比较超声、PET/CT和DW-MRI在宫颈癌患者术前评估盆腔淋巴结诊断准确性的研究:CANNES试验结果

2026-05-240
OA
The incidence of low volume metastases according to Silva pattern in cervical adenocarcinoma undergoing sentinel lymph node biopsy.

根据Silva模式,接受哨兵淋巴结活检的宫颈腺癌中低体积转移的发生率。

2026-05-080
OAAI
Highlights from the 26th European Congress on Gynaecological Oncology in Copenhagen: Interview compilation of the ENYGO-IJGC editorial fellows

第26届欧洲妇科肿瘤学大会在哥本哈根的亮点:ENYGO-IJGC编辑团队成员的采访汇编

2026-04-260
PRE
One Step Nucleic Acid Amplification (OSNA) versus ultrastaging to detect sentinel lymph node metastasis in endometrial cancer: a randomized, multicenter, controlled trial (SENT-OSNA trial).

一步核酸扩增(OSNA)与超分期检测子宫内膜癌前哨淋巴结转移的比较:一项随机、多中心、对照试验(SENT-OSNA试验)。

2026-02-160
OAAI
Response to the Correspondence by Xu et al. on “Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study” by Mascilini et al.

对Xu等人关于“化学放射疗法后超声引导活检检测复发性或持续性宫颈癌的诊断性能:一项前瞻性、单中心研究”的Mascilini等人通信的回应

2025-12-180
PRE
Surgical Timing in Advanced Ovarian Cancer During the TRUST Trial Era: A Systematic Review, Meta-Analysis and Study-Level Meta-regression of Randomized Controlled Trials

TRUST试验时期晚期卵巢癌的手术时机:一项系统评价、随机对照试验的Meta分析及研究水平的Meta回归

2025-12-180
OAAI
Electronic Nose-Based Volatile Organic Compound Profiling in Gynecologic Oncology: Current Evidence and Diagnostic Accuracy

基于电子鼻的挥发性有机化合物在妇科肿瘤学中的特征分析:当前证据与诊断准确性

2025-12-160
OAAI
COmplications and REcurrence after Pelvic EXenteration for gynecologic malignancies: analysis of surgical complications from the COREPEX study.

盆腔廓清术后妇科恶性肿瘤的并发症与复发:COREPEX研究中手术并发症的分析。

2025-11-250
OAAI
The Hugo™ RAS system in gynecologic robotic surgery: a systematic review of current applications

Hugo™ RAS系统在妇科机器人手术中的应用:当前应用的系统评价

2025-11-170
OAAI
Robotic-assisted uterine transposition for fertility preservation in patients treated with radiotherapy for pelvic malignancies: from transposition to repositioning.

机器人辅助的子宫移位术用于接受盆腔恶性肿瘤放疗患者的生育力保护:从移位到复位。

2025-11-080
PRE